
- Pharmaceutical Commerce - May/June 2011
Oracle updates applications for clinical trial management, adverse-event reporting
Emphasis is on operating a single instance for multiple clients
Oracle has a new version, 7.0 of Argus Safety, the business it acquired a couple years ago, and has also updated Oracle Clinical, Oracle Remote Data Capture and Oracle Thesaurus Management System, which collectively help drug sponsors and contract research organizations (CROs) to manage pre- and post-commercial clinical studies and data management. Both the Argus Safety and Clinical products are now interfaced with Oracle 11g, the latest version of its database management technology; additional the Oracle Clinical products have “seamless” integration with the Siebel Clinical Trial Management System, which provides planning and overall management of clinical trial processes.
Adverse event reports (AERs) are a
The clinical tools have been redesigned to enable adaptive clinical trials, in which the parameters and endpoints of the trial can evolve as the trial progresses; adaptive trials are one of the methods researchers are using to extract more value, more quickly, from the clinical research process. The integration with Siebel is carried out via an Oracle Application Infrastructure Architecture process integration pack (PIP), Oracle’s method of unifying the wide array of developed or acquired software tools it markets.
Articles in this issue
over 14 years ago
Introover 14 years ago
What Makes a Pharmaceutical Industry Leader?over 14 years ago
How REMS Affect Pharmaceutical Distribution Processes and Partnersover 14 years ago
Patient-Administered Therapies Drive New Delivery System Designsover 14 years ago
For a Lucky Few, Biopharma Expansion a Reality Againover 14 years ago
Making Pallets a Supply Chain Asset Instead of an Unrecoverable CostNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.




